Belgium
Highlights of the performance of our Belgian business in 2024
Inflows increased by 5% thanks to strong growth in Non-Life (+8%) and were supported by Life inflows that returned to growth (+3%). New business sales and price increases equally contributed to Non-Life inflow growth. Life inflows rose thanks to higher Group Life & Invest sales.
Life Guaranteed margin stood at a very strong 98 bps significantly above the target range, driven by an excellent insurance result. The Unit-Linked margin reached 45 bps, up compared to last year, surpassing the target range.
The Non-Life Combined ratio stood at a strong 91.8% and included the weather impact that was in line with the long-term average (-2.8pp) but higher compared to last year (-2.1pp).
The Net Operating Result amounted to a solid EUR 468 million with EUR 330 million from Life and EUR 139 million from Non-Life. The decrease compared to last year is explained by an exceptionally strong Non-Life result in 2023 that benefited from high prior year releases in Accident & Health. The solid operational performance and margin improvement were also reflected in an Operational Capital Generation of EUR 651 million.





